Using bradykinin-potentiating peptide structures to develop new antihypertensive drugs

Genetics and Molecular Research

Volumn 3, Issue 4, 2004, Pages 554-563

  Fernandez, Jorge Hernandez ^a   Neshich, Goran ^b   Camargo, Antonio Carlos M ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b Structural Bioinformatic Laboratory   (Brazil)

Author keywords

Angiotensin I converting enzyme; Bradykinin potentiating peptides; Hypertension; Modeling; Molecular dynamics

Indexed keywords

ANTIHYPERTENSIVE AGENT; BATROXOBIN; BRADYKININ POTENTIATING PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; LISINOPRIL; PEPTIDASE; PEPTIDE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; ENZYME INHIBITION; EXTRACTION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; MOLECULAR STABILITY; PROTEIN DOMAIN; PROTEIN STRUCTURE; SNAKE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BOTHROPS; BRADYKININ; CATALYTIC DOMAIN; CROTALID VENOMS; DRUG DESIGN; DRUG SYNERGISM; HUMANS; MODELS, MOLECULAR; OLIGOPEPTIDES; SUBSTRATE SPECIFICITY;

BOTHROPS JARARACA; SERPENTES;

EID: 14644422690     PISSN: 16765680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Andújar-Sánchez, M., Cámara-Artigas, A. and Jará-Pérez, V. (2004). A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme. Biophys. Chem. 111: 183-189.
2. Brown, C.K., Madauss, K., Lian, W., Beck, M.R., Tolbert, W.D. and Rodgers, D.W. (2001). Structure of neurolysin reveals a deep channel that limits substrate access. Proc. Natl. Acad. Sci. USA 98: 3127-3132.
3. Camargo, A.C.M. and Hayashi, M.A.F. (2005). The bradykinin-potentiating peptides from the venom gland and brain of Bothrops jararaca contain highly site-specific inhibitors of the somatic angiotensin-converting enzyme. Toxicon (in press).
4. Cotton, J., Hayashi, M.A., Cuniasse, P., Vazeux, G., Ianzer, D., Camargo, A.C.M. and Dive, V. (2002). Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides. Biochemistry 41: 6065-6071.
5. Essman, U., Perela, L., Berkowitz, M.L., Darden, T., Lee, H. and Pedersen, L.G. (1995). A smooth particle mesh Ewald method. J. Chem. Phys. 103: 8577-8592.
6. Fernandez, J.H., Hayashi, M.A., Camargo, A.C.M. and Neshich, G. (2003). Structural basis of the lisinoprilbinding specificity in N- and C-domains of human somatic ACE. Biochem. Biophys. Res. Commun. 22: 219-226.
7. Ferreira, S.H., Bartelt, D.C. and Greene, L.J. (1970). Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 9: 2583-2593.
8. Fiser, A., Do, R.K. and Sali, A. (2000). Modeling of loops in protein structures. Protein Sci. 9: 1753-1773.
9. Hayashi, M.A., Murbach, A.F., Ianzer, D., Portaro, F.C., Prezoto, B.C., Fernandez, B.L., Silveira, P.F., Silva, C.A., Pires, R.S., Britto, L.R., Dive, V. and Camargo, A.C.M. (2003). The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme. J. Neurochem. 85: 969-977.
10. Humphrey, W., Dalke, A. and Schulten, K. (1996). "VMD - Visual Molecular Dynamics". J. Mol. Graph. 14: 33-38.
11. Ianzer, D., Konno, K., Marques-Porto, R., Vieira Portaro, F.C., Stocklin, R., Martins de Camargo, A.C. and Pimenta, D.C. (2004). Identification of five new bradykinin potentiating peptides (BPPs) from Bothrops jararaca crude venom by using electrospray ionization tandem mass spectrometry after a two-step liquid chromatography. Peptides 25: 1085-1092.
12. Jaspard, E., Wei, L. and Alhenc-Gelas, F. (1993). Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J. Biol. Chem. 268: 9496-9503.
13. Kim, H.M., Shin, D.R., Yoo, O.J., Lee, H. and Lee, J.O. (2003). Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril. FEBS Lett. 538: 65-70.
14. Laskowski, R.A., MacArthur, M.W., Moss, D.S. and Thornton, J.M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26: 283-291.
15. Lindahl, E., Hess, B. and van der Spoel, D. (2001). GROMACS 3.0: A Package for molecular simulation and trajectory analysis. J. Mol. Mod. 7: 306-317.
16. Liu, X., Fernandez, M., Wouters, M.A., Heyberger, S. and Husain, A. (2001). Arg(1098) is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity. J. Biol. Chem. 276: 33518-33525.
17. Louie, T.M., Yang, H., Karnchanaphanurach, P., Xie, X.S. and Xun, L. (2002). FAD is a preferred substrate and an inhibitor of Escherichia coli general NAD(P)H:flavin oxidoreductase. J. Biol. Chem. 277: 39450-39455.
18. Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K. and Olson, A.J. (1998). Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J. Comput. Chem.19: 1639-1662.
19. Natesh, R., Schwager, S.L.U., Sturrock, E.D. and Acharya, K.R. (2003). Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 421: 551-554.
20. Natesh, R., Schwager, S.L.U., Evans, H.R., Sturrock, E.D. and Acharya, K.R. (2004). Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry 43: 8718-8724.
21. Neshich, G., Togawa, R.C., Mancini, A.L., Kuser, P.R., Yamagishi, M.E., Pappas Jr., G., Torres, W.V., Fonseca e Campos, T., Ferreira, L.L., Luna, F.M., Oliveira, A.G., Miura, R.T., Inoue, M.K., Horita, L.G., de Souza, D.F., Dominiquini, F., Alvaro, A., Lima, C.S., Ogawa, F.O., Gomes, G.B., Palandrani, J.F., dos Santos, G.F., de Freitas, E.M., Mattiuz, A.R., Costa, I.C., de Almeida, C.L., Souza, S., Baudet, C. and Higa, R.H. (2003). STING Millennium: A web-based suite of programs for comprehensive and simultaneous analysis of protein structure and sequence. Nucleic Acids Res. 31: 3386-3392.
22. Ng, K.K. and Vane, J.R. (1970). Some properties of angiotensin converting enzyme in the lung in vivo. Nature 225: 1142-1144.
23. Ondetti, M.A. and Cushman, D.W. (1981). Angiotensin converting enzyme inhibitors: biochemical properties and biological activities. In: Biochemical Regulation of Blood Pressure (Soffer, R.L., ed.). Wiley, New York, NY, USA, pp. 165-204.
24. Ray, K., Hines, C.S., Coll-Rodriguez, J. and Rodgers, D.W. (2004). Crystal structure of human thimet oligopeptidase provides insight into substrate recognition, regulation, and localization. J. Biol. Chem. 279: 20480-20489.
25. Riordan, J.F. (2003). Angiotensin-I-converting enzyme and its relatives. Genome Biol. 4: 225-229.
26. Rocha e Silva, M., Beraldo, W.T. and Rosenfeld, G. (1949). Bradykinin, a hypotensive and a smooth muscle stimulating factor released from plasma globulin by snake venom and by trypsin. Am. J. Physiol. 156: 261-270.
27. Rousseau, A., Michaud, A., Chauvet, M.T., Lenfant, M. and Corvol, P. (1995). The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J. Biol. Chem. 270: 3656-3661.
28. Sali, A. and Blundell, T.L. (1993). Comparative protein modeling by satisfaction of spatial restraints. J. Mol. Biol. 234: 779-815.
29. Thompson, J.D., Gibson, T.J., Plewniak, F., Jeanmougin, F. and Higgins, D.G. (1997). The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25: 4876-4882.
30. Towler, P., Staker, B., Prasad, S.G., Menon, S., Tang, J., Parsons, T., Ryan, D., Fisher, M., Williams, D., Dales, N.A., Patane, M.A. and Pantoliano, M.W. (2004). ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. 279: 17996-18007.
31. Villard, E. and Soubrier, F. (1996). Molecular biology and genetics of the angiotensin-I-converting enzyme: potential implications in cardiovascular diseases. Cardiovasc. Res. 32: 999-1007.
32. Wei, L., Alhenc-Gelas, F., Corvol, P. and Clauser, E. (1991). The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem. 266: 9002-9008.